Shaw-Jenq Tsai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shaw-Jenq Tsai has a total of 369 co-authors. Here are the top co-authors by number of shared publications:
- Hsiao Fang Sunny Sun
Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
31 shared publications Meng-Hsing Wu
Department of Obstetrics and Gynecology, College of Medicine, National Cheng Kung University , Tainan
31 shared publicationsShih-Chieh Lin
17 shared publications- Kuei-Yang Hsiao
Institute of Biochemistry, College of Life Sciences, National Chung Hsing University, Taichung, Taiwan
16 shared publications Pei-Chin Chuang
Department of Medical Research, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
13 shared publicationsChu-An Wang
Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
11 shared publications
Latest Publications
- 10 November 2026
- Published by Elsevier in Drug Resistance Updates
- Vol. 90
CARM1 orchestrates hypoxia-mediated chemoresistance through the H3R17me2a/FUS upregulation in colorectal cancer
- 10 November 2026
- Published by Elsevier in Drug Resistance Updates
- Vol. 90
CARM1 orchestrates hypoxia-mediated chemoresistance through the H3R17me2a/FUS upregulation in colorectal cancer
- 2 June 2026
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 171 (6)
Interleukin-17A as a key driver for cell migration, proliferation, inflammation, and nerve infiltration in deep endometriosis
In brief: Deep endometriosis is a highly invasive and severely painful disorder. This study identifies interleukin-17A as a central mediator that links immune-driven inflammation to the acquisition of pathogenic behaviors, including proliferation, invasion, and nerve infiltration, thereby the aggressive and pain-associated phenotypes of deep endometriosis. Deep endometriosis (DE) is the most severe subtype of endometriosis, marked by aggressive cellular behavior and debilitating pain. However, the molecular mechanisms underlying DE pathogenesis remain poorly understood. In this study, we identified interleukin (IL)-17A as a critical mediator driving the pathological processes of DE. The level of IL-17A was elevated in DE tissues, with T cells, mast cells, macrophages, and endometriosis stromal cells as sources of IL-17A. Functional assays demonstrated that IL-17A stimulates the proinflammatory cytokines such as IL-1β and IL-6 as well as enhancing the proliferative and migratory capacities through activation of ERK1/2 and Notch1 signaling pathways. Immunohistochemical (IHC) staining further revealed that levels of NICD and Ki67 are abundant and positively correlates with each other in DE lesions. In addition, PGP9.5+ nerves bundles are evidently detected in DE tissues as compared with normal endometria, pelvic endometriotic lesions, and ovarian endometrioma, which reflects the nature of severe pain in DE patients. Treatment with IL-17A induces the expression of nerve growth factor (NGF), a peptide growth factor to induce nerve infiltration. The IHC staining revealed a significant positive correlation between PGP9.5+ nerves and NGF signals specifically in DE lesions. Collectively, these findings suggest that IL-17A promotes DE lesion progression by sustaining chronic inflammation and enhancing endometrial stromal cells proliferation, migration, and nerve infiltration, thereby contributing to inflammation-associated neuropathic pain in affected patients.
- 2 June 2026
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 171 (6)
Interleukin-17A as a key driver for cell migration, proliferation, inflammation, and nerve infiltration in deep endometriosis
In brief: Deep endometriosis is a highly invasive and severely painful disorder. This study identifies interleukin-17A as a central mediator that links immune-driven inflammation to the acquisition of pathogenic behaviors, including proliferation, invasion, and nerve infiltration, thereby the aggressive and pain-associated phenotypes of deep endometriosis. Deep endometriosis (DE) is the most severe subtype of endometriosis, marked by aggressive cellular behavior and debilitating pain. However, the molecular mechanisms underlying DE pathogenesis remain poorly understood. In this study, we identified interleukin (IL)-17A as a critical mediator driving the pathological processes of DE. The level of IL-17A was elevated in DE tissues, with T cells, mast cells, macrophages, and endometriosis stromal cells as sources of IL-17A. Functional assays demonstrated that IL-17A stimulates the proinflammatory cytokines such as IL-1β and IL-6 as well as enhancing the proliferative and migratory capacities through activation of ERK1/2 and Notch1 signaling pathways. Immunohistochemical (IHC) staining further revealed that levels of NICD and Ki67 are abundant and positively correlates with each other in DE lesions. In addition, PGP9.5+ nerves bundles are evidently detected in DE tissues as compared with normal endometria, pelvic endometriotic lesions, and ovarian endometrioma, which reflects the nature of severe pain in DE patients. Treatment with IL-17A induces the expression of nerve growth factor (NGF), a peptide growth factor to induce nerve infiltration. The IHC staining revealed a significant positive correlation between PGP9.5+ nerves and NGF signals specifically in DE lesions. Collectively, these findings suggest that IL-17A promotes DE lesion progression by sustaining chronic inflammation and enhancing endometrial stromal cells proliferation, migration, and nerve infiltration, thereby contributing to inflammation-associated neuropathic pain in affected patients.
- 30 March 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
Hypoxia-induced miR-21-5p promotes autophagy by downregulating CDC25A in endometriosis
Endometriosis is a common gynecological disorder affecting women of reproductive age, often leading to chronic pain, reduced quality of life, and infertility. It is characterized by ectopic endometrial growth within a hypoxic peritoneal environment. Autophagy, a cellular recycling pathway, is elevated in ectopic lesions. However, how hypoxia regulates autophagy to drive lesion development remains unclear. We found that inhibition of autophagy with chloroquine reduced stromal cell growth under hypoxia. The microRNA miR-21-5p, previously shown to be elevated by hypoxia in ectopic lesions, was examined and found to target cell division cycle 25A (CDC25A). Overexpression of miR-21-5p suppressed CDC25A. Under hypoxia, yes-associated protein 1 (YAP1) nuclear accumulation increased miR-21-5p, which in turn further reduced CDC25A expression. Silencing CDC25A enhanced autophagic flux, whereas pharmacologic inhibition of YAP1 with verteporfin restored CDC25A and p62 in mouse lesions and reduced lesion size. Collectively, these findings demonstrate that hypoxia activates YAP1-driven miR-21-5p, which represses CDC25A to promote autophagy and sustain lesion survival, highlighting the miR-21-5p/CDC25A axis as a potential therapeutic target.
- 30 March 2026
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
Hypoxia-induced miR-21-5p promotes autophagy by downregulating CDC25A in endometriosis
Endometriosis is a common gynecological disorder affecting women of reproductive age, often leading to chronic pain, reduced quality of life, and infertility. It is characterized by ectopic endometrial growth within a hypoxic peritoneal environment. Autophagy, a cellular recycling pathway, is elevated in ectopic lesions. However, how hypoxia regulates autophagy to drive lesion development remains unclear. We found that inhibition of autophagy with chloroquine reduced stromal cell growth under hypoxia. The microRNA miR-21-5p, previously shown to be elevated by hypoxia in ectopic lesions, was examined and found to target cell division cycle 25A (CDC25A). Overexpression of miR-21-5p suppressed CDC25A. Under hypoxia, yes-associated protein 1 (YAP1) nuclear accumulation increased miR-21-5p, which in turn further reduced CDC25A expression. Silencing CDC25A enhanced autophagic flux, whereas pharmacologic inhibition of YAP1 with verteporfin restored CDC25A and p62 in mouse lesions and reduced lesion size. Collectively, these findings demonstrate that hypoxia activates YAP1-driven miR-21-5p, which represses CDC25A to promote autophagy and sustain lesion survival, highlighting the miR-21-5p/CDC25A axis as a potential therapeutic target.
- 16 October 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (2) , 381-383
Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility and renal function impact
This study investigated serum zinc levels in patients with bullous pemphigoid (BP) and identified a high prevalence of zinc deficiency, particularly among those with low body mass index, chronic kidney disease and hypertension. Zinc supplementation was associated with improved renal function and reduced skin fragility, highlighting its potential therapeutic role in managing BP.
- 16 October 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (2) , 381-383
Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility and renal function impact
This study investigated serum zinc levels in patients with bullous pemphigoid (BP) and identified a high prevalence of zinc deficiency, particularly among those with low body mass index, chronic kidney disease and hypertension. Zinc supplementation was associated with improved renal function and reduced skin fragility, highlighting its potential therapeutic role in managing BP.
- Open Access
- 2 September 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (17)
Corrigendum to Suppression of dual-specificity phosphatase–2 by hypoxia increases chemoresistance and malignancy in human cancer cells
- 2 September 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (17)
Open AccessCorrigendum to Suppression of dual-specificity phosphatase–2 by hypoxia increases chemoresistance and malignancy in human cancer cells
- Open Access
- 16 January 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
Melanophilin-induced primary cilia promote pancreatic cancer metastasis
Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors because of its high metastatic ability. The glutamine (Gln)-deficient microenvironment contributes to PDAC metastasis; however, the underlying molecular mechanisms remain unclear. Here, we demonstrated that melanophilin (MLPH) promotes PDAC metastasis by inducing the regrowth of primary cilia. Using RNA sequencing, we found that MLPH was upregulated in Gln-deficient conditions. MLPH facilitated PDAC metastasis in vitro and in vivo. Clinically, high MLPH expression is positively correlated with metastasis and poor PDAC prognosis. MLPH localized to the centrosome and facilitated the regrowth of primary cilia. The primary ciliogenesis upregulated phospholipase C γ-1 (PLCG1) to promote PDAC metastasis. Interestingly, PLCG1 was localized to the primary cilia, and depletion of PLCG1 alleviated primary ciliogenesis, suggesting a feedforward role for PLCG1 in mediating primary ciliogenesis. Thus, our study revealed a novel function of the MLPH-primary cilia-PLCG1 axis in facilitating PDAC metastasis under Gln deficiency both in vitro and in vivo.
- 16 January 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-14
Open AccessMelanophilin-induced primary cilia promote pancreatic cancer metastasis
Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors because of its high metastatic ability. The glutamine (Gln)-deficient microenvironment contributes to PDAC metastasis; however, the underlying molecular mechanisms remain unclear. Here, we demonstrated that melanophilin (MLPH) promotes PDAC metastasis by inducing the regrowth of primary cilia. Using RNA sequencing, we found that MLPH was upregulated in Gln-deficient conditions. MLPH facilitated PDAC metastasis in vitro and in vivo. Clinically, high MLPH expression is positively correlated with metastasis and poor PDAC prognosis. MLPH localized to the centrosome and facilitated the regrowth of primary cilia. The primary ciliogenesis upregulated phospholipase C γ-1 (PLCG1) to promote PDAC metastasis. Interestingly, PLCG1 was localized to the primary cilia, and depletion of PLCG1 alleviated primary ciliogenesis, suggesting a feedforward role for PLCG1 in mediating primary ciliogenesis. Thus, our study revealed a novel function of the MLPH-primary cilia-PLCG1 axis in facilitating PDAC metastasis under Gln deficiency both in vitro and in vivo.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12588
Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives
Background: Endometriosis is a common gynecological disease affecting women of reproductive age. Patients with endometriosis frequently experience severe chronic pain and have higher chances to experience infertility. Progesterone resistance is a major problem that develops during the medical treatment of endometriosis, which often leads to treatment failure of hormonal therapies. Previous studies indicated that the dysregulation of progesterone receptors (PR) is the primary factor leading to progesterone resistance in endometriosis.Methods: This review article systematically reviewed and summarized findings extracted from previously published papers available on PubMed, encompassing both experimental studies and clinical trials.Main findings: Various determinants influencing PR expression in endometriosis have been identified, including the environmental toxins, microRNAs, cell signaling pathways, genetic mutations, and the pro‐inflammatory cytokines. The selective estrogen/progesterone receptor modulators have emerged as novel therapeutic approaches for treating endometriosis, offering potential improvements in overcoming progesterone resistance.Conclusion: Concerns and limitations persist despite the newly developed drugs. Therefore, studies on unraveling new therapeutic targets based on the molecular mechanisms of progesterone resistance is warranted for the development potential alternatives to overcome hormonal treatment failure in endometriosis.
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12588
Top Cited PapersOpen AccessProgesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives
Background: Endometriosis is a common gynecological disease affecting women of reproductive age. Patients with endometriosis frequently experience severe chronic pain and have higher chances to experience infertility. Progesterone resistance is a major problem that develops during the medical treatment of endometriosis, which often leads to treatment failure of hormonal therapies. Previous studies indicated that the dysregulation of progesterone receptors (PR) is the primary factor leading to progesterone resistance in endometriosis.Methods: This review article systematically reviewed and summarized findings extracted from previously published papers available on PubMed, encompassing both experimental studies and clinical trials.Main findings: Various determinants influencing PR expression in endometriosis have been identified, including the environmental toxins, microRNAs, cell signaling pathways, genetic mutations, and the pro‐inflammatory cytokines. The selective estrogen/progesterone receptor modulators have emerged as novel therapeutic approaches for treating endometriosis, offering potential improvements in overcoming progesterone resistance.Conclusion: Concerns and limitations persist despite the newly developed drugs. Therefore, studies on unraveling new therapeutic targets based on the molecular mechanisms of progesterone resistance is warranted for the development potential alternatives to overcome hormonal treatment failure in endometriosis.
- 18 August 2023
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 29 (10) , 780-782
Feel so bac: is Fusobacterium the suspect causing endometriosis?
- 18 August 2023
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 29 (10) , 780-782
Feel so bac: is Fusobacterium the suspect causing endometriosis?
- 4 August 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (6) , 719-729
Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa
Hidradenitis suppurativa significantly diminishes the quality of life for patients. Delayed diagnosis represents a significant challenge in effectively managing hidradenitis suppurativa. To identify and characterize the key mediator in hidradenitis suppurativa. Bioinformatic analysis of transcriptomic was applied to identify potential candidates contributing to the disease process of hidradenitis suppurativa. Skin samples from 40 patients with hidradenitis suppurativa, four with psoriasis, and 29 with normal skin were included. The expression of interleukin (IL)-17A was evaluated and compared among normal skin, psoriasis, and different stages of hidradenitis suppurativa samples by immunohistochemistry or dual-color immunofluorescence. In-vitro experiments and RNA-seq analysis were also conducted to validate the expression of IL-17A and its pathogenic effect in hidradenitis suppurativa. Transcriptomic database analyses identified IL-17 signaling as a potential contributor to hidradenitis suppurativa. In hidradenitis suppurativa, the predominant IL-17A+ cell population was identified as mast cells. IL-17A+ mast cell density was significantly elevated in hidradenitis suppurativa, especially in samples with advanced Hurley stages, compared with normal skin and psoriasis samples. The close contact between IL-17A+ mast cells and IL-17 receptor (IL-17RA)-expressing keratinocytes was demonstrated, along with the significant effects of IL-17A on keratinocyte cell proliferation and hidradenitis suppurativa pathogenic gene expression. Treatment with biologics (brodalumab or adalimumab) reduced the severity of the disease and the number of IL-17A+ mast cells in affected tissues. The presence of high-density IL-17A+ mast cells may serve as a valuable pathological marker for diagnosing hidradenitis suppurativa. Moreover, developing therapeutic drugs targeting IL-17A+ mast cells may provide a new approach to treating hidradenitis suppurativa.
- 4 August 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (6) , 719-729
Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa
Hidradenitis suppurativa significantly diminishes the quality of life for patients. Delayed diagnosis represents a significant challenge in effectively managing hidradenitis suppurativa. To identify and characterize the key mediator in hidradenitis suppurativa. Bioinformatic analysis of transcriptomic was applied to identify potential candidates contributing to the disease process of hidradenitis suppurativa. Skin samples from 40 patients with hidradenitis suppurativa, four with psoriasis, and 29 with normal skin were included. The expression of interleukin (IL)-17A was evaluated and compared among normal skin, psoriasis, and different stages of hidradenitis suppurativa samples by immunohistochemistry or dual-color immunofluorescence. In-vitro experiments and RNA-seq analysis were also conducted to validate the expression of IL-17A and its pathogenic effect in hidradenitis suppurativa. Transcriptomic database analyses identified IL-17 signaling as a potential contributor to hidradenitis suppurativa. In hidradenitis suppurativa, the predominant IL-17A+ cell population was identified as mast cells. IL-17A+ mast cell density was significantly elevated in hidradenitis suppurativa, especially in samples with advanced Hurley stages, compared with normal skin and psoriasis samples. The close contact between IL-17A+ mast cells and IL-17 receptor (IL-17RA)-expressing keratinocytes was demonstrated, along with the significant effects of IL-17A on keratinocyte cell proliferation and hidradenitis suppurativa pathogenic gene expression. Treatment with biologics (brodalumab or adalimumab) reduced the severity of the disease and the number of IL-17A+ mast cells in affected tissues. The presence of high-density IL-17A+ mast cells may serve as a valuable pathological marker for diagnosing hidradenitis suppurativa. Moreover, developing therapeutic drugs targeting IL-17A+ mast cells may provide a new approach to treating hidradenitis suppurativa.
- Open Access
- 21 June 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (12)
Optogenetically engineered Ca2+ oscillation-mediated DRP1 activation promotes mitochondrial fission and cell death
Mitochondrial dynamics regulate the quality and morphology of mitochondria. Calcium (Ca2+) plays an important role in regulating mitochondrial function. Here, we investigated the effects of optogenetically engineered Ca2+ signaling on mitochondrial dynamics. More specifically, customized illumination conditions could trigger unique Ca2+ oscillation waves to trigger specific signaling pathways. In this study, we found that modulating Ca2+ oscillations by increasing the light frequency, intensity and exposure time could drive mitochondria toward the fission state, mitochondrial dysfunction, autophagy and cell death. Moreover, illumination triggered phosphorylation at the Ser616 residue but not the Ser637 residue of the mitochondrial fission protein, dynamin-related protein 1 (DRP1, encoded by DNM1L), via the activation of Ca2+-dependent kinases CaMKII, ERK and CDK1. However, optogenetically engineered Ca2+ signaling did not activate calcineurin phosphatase to dephosphorylate DRP1 at Ser637. In addition, light illumination had no effect on the expression levels of the mitochondrial fusion proteins mitofusin 1 (MFN1) and 2 (MFN2). Overall, this study provides an effective and innovative approach to altering Ca2+ signaling for controlling mitochondrial fission with a more precise resolution than pharmacological approaches in the temporal dimension.
- 21 June 2023
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 136 (12)
Open AccessOptogenetically engineered Ca2+ oscillation-mediated DRP1 activation promotes mitochondrial fission and cell death
Mitochondrial dynamics regulate the quality and morphology of mitochondria. Calcium (Ca2+) plays an important role in regulating mitochondrial function. Here, we investigated the effects of optogenetically engineered Ca2+ signaling on mitochondrial dynamics. More specifically, customized illumination conditions could trigger unique Ca2+ oscillation waves to trigger specific signaling pathways. In this study, we found that modulating Ca2+ oscillations by increasing the light frequency, intensity and exposure time could drive mitochondria toward the fission state, mitochondrial dysfunction, autophagy and cell death. Moreover, illumination triggered phosphorylation at the Ser616 residue but not the Ser637 residue of the mitochondrial fission protein, dynamin-related protein 1 (DRP1, encoded by DNM1L), via the activation of Ca2+-dependent kinases CaMKII, ERK and CDK1. However, optogenetically engineered Ca2+ signaling did not activate calcineurin phosphatase to dephosphorylate DRP1 at Ser637. In addition, light illumination had no effect on the expression levels of the mitochondrial fusion proteins mitofusin 1 (MFN1) and 2 (MFN2). Overall, this study provides an effective and innovative approach to altering Ca2+ signaling for controlling mitochondrial fission with a more precise resolution than pharmacological approaches in the temporal dimension.